Searched for
EMCURE EBITDA
Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....- Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun PharmaIndian equity benchmarks experienced gains, with Nifty nearing the 23,500 resistance level and strong corporate earnings reported. ITC face...
- Emcure Pharma net profit up 36% at Rs 292 croreEmcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...
- Emcure Pharma Q1 profit jumps 36%, revenue rises 23%; appoints Samit Mehta as COO"We have begun FY27, the second year of our five-year plan—on a strong footing. FY26 was about putting the building blocks in place across ...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Warburg, Bain, CVC among PE firms in talks to buy into Agappe DiagnosticsSeveral global private equity firms are exploring a significant stake purchase in Agappe Diagnostics. This potential deal involves both exi...
- Emcure eyes India growth, global deals amid strong demandEmcure Pharmaceuticals is boosting domestic expansion, R&D, and manufacturing. The company is also exploring acquisition opportunities in I...
- Emcure Pharma shares in focus after GST Department conducts search at Mumbai officesEmcure Pharmaceuticals' shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded t...
- Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growthPune-based Emcure Pharmaceuticals reported a 13.4% year-on-year rise in consolidated revenue to ₹2,270 crore in the September quarter, supp...
- Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growthEmcure Pharmaceuticals reported a strong first quarter with a 41% increase in net profit, reaching Rs 215 crore, and a 16% rise in revenue ...
- Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growthEmcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit to Rs 197 crore, driven by strong domestic and international growth. EBITDA...
- Emcure Pharma Q3 net profit rises 30% YoY to Rs 156 croreEmcure Pharmaceuticals on Thursday reported a 30.3% year-on-year (YoY) increase in net profit to Rs.156 crore in Q3FY25 led by strong perfo...
- Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stockDriven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal chall...
- Emcure Pharma Q2 Results: Net profit rises 38% to Rs 202 crore, revenue jumps 20%Emcure Pharmaceuticals reported a 38.2% YoY rise in Q2FY25 net profit to Rs 202 crore, driven by strong domestic and international sales. R...
- Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue fr...
- Mankind to use debt, internal accruals to fund BSV buyoutMankind Pharma announced a ₹13,630 crore acquisition of Bharat Serums and Vaccines (BSV) to be funded through internal accruals and a mix o...
- Bansal Wire IPO shares to debut on Wednesday. What GMP signals ahead of listingBansal Wire shares will debut on the bourses on Wednesday. Ahead of the listing, the company's shares were trading with a grey market premi...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- UltraTech's India Cements stake buy a win-win for both. Here's what analyst said on industry consolidationUltraTech Cement's Rs 1,885 crore stake purchase in India Cements is expected to be mutually beneficial for both companies and would consol...
- Mankind Pharma files DRHP for Rs 5,500 crore IPOThe company’s initial public offering comprises an offer for the sale of 4 crore equity shares by the promoters and existing investors.The ...
Load More
